Charles River buys WuXi PharmaTech in $1.6 billion deal
Pharmaceutical research company Charles River pays $1.6 billion in cash and stock to acquire Chinese outsourcing company WuXi PharmaTech two-and-a-half years after its listing in the US.
April 26, 2010